Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2017-07-14 Earnings Release
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Profit Warning
Earnings Release Classification · 95% confidence The document is a profit warning announcement made pursuant to the Listing Rules and Inside Information Provisions. It provides a preliminary assessment of the company's expected consolidated net loss increase for the six months ended 30 June 2017, but explicitly states that the information is preliminary, unaudited, and subject to further review. It does not contain actual financial statements or detailed financial data, nor is it the full interim report. The document is relatively short (4167 characters) and serves as an announcement to inform shareholders and investors about expected financial performance before the official interim results are published. According to the classification rules, such preliminary profit warnings or earnings outlook announcements are best classified as Earnings Release (ER), which covers initial announcements of quarterly or periodical financial results with key highlights only. H1 2017
2017-07-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2017
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/6/2017. It details movements in authorized and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and movements during a specific month, submitted to the Hong Kong Exchanges and Clearing Limited. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting share capital movements for a monthly period, which fits the category of Share Issue/Capital Change announcements rather than a full financial report or other categories.
2017-07-03 English
Environmental, Social and Governance Report 2016
Environmental & Social Information Classification · 100% confidence The document is titled 'Environmental, Social and Governance Report 2016' and contains detailed sections on environmental protection, emissions management, resource utilization, employment and labor practices, and community investment. It references compliance with the Environmental, Social and Governance Reporting Guide under Appendix 27 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. The content focuses on ESG factors rather than financial performance or corporate governance structure. The length is substantial (15,000 characters) and the content is a full report, not an announcement or certification. Therefore, the document fits the category of Environmental & Social Information (SR).
2017-06-30 English
Poll Results of the Annual General Meeting held on 2 June 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from the Annual General Meeting (AGM) held on 2 June 2017. It details the voting outcomes on various resolutions including receiving the audited financial statements, re-election of directors, appointment of auditors, and granting a general mandate to issue shares. The document is relatively short (2979 characters) and focuses on the voting results rather than providing the full AGM materials or presentations. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2017-06-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2017
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/5/2017. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory disclosure related to share capital movements submitted to the Hong Kong Exchanges and Clearing Limited. This type of document fits best under 'Share Issue/Capital Change' (SHA) as it reports on changes in share capital and related securities.
2017-06-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/4/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements rather than a full financial report or announcement of a report. The document length is substantial (14,688 characters), indicating it is a detailed report rather than a brief announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a regulatory compliance document reporting share capital movements that do not fit into other specific categories like Share Issue/Capital Change (SHA) because it is a monthly return report rather than a single capital change event.
2017-05-02 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.